MEDICURE INC. Files October 6-K Report
Ticker: MCUJF · Form: 6-K · Filed: Oct 25, 2024 · CIK: 1133519
| Field | Detail |
|---|---|
| Company | Medicure Inc (MCUJF) |
| Form Type | 6-K |
| Filed Date | Oct 25, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, regulatory-update
TL;DR
Medicare Inc. filed its monthly 6-K, confirming 20-F annual report filing.
AI Summary
On October 25, 2024, MEDICURE INC. filed a Form 6-K for the month of October 2024. The company, based in Winnipeg, Canada, is a pharmaceutical preparations manufacturer. This filing indicates they will file their annual reports under Form 20-F.
Why It Matters
This filing provides routine updates for investors and the SEC, confirming Medicare Inc.'s reporting status and adherence to regulatory requirements.
Risk Assessment
Risk Level: low — This is a routine filing that does not contain new financial information or significant operational updates.
Key Numbers
- 001-31995 — SEC File Number (Identifies the company's filing with the SEC.)
Key Players & Entities
- MEDICURE INC. (company) — Registrant
- 001-31995 (company) — SEC File Number
- 20241025 (date) — Filing Date
- October 2024 (date) — Reporting Period
- Winnipeg, Canada (company) — Company Location
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, typically used to provide information that the company makes or is required to make public in its home country.
Which annual report form does MEDICURE INC. use?
MEDICURE INC. indicates it files its annual reports under cover of Form 20-F.
What is the principal executive office address of MEDICURE INC.?
The principal executive offices are located at 2-1250 Waverley Street, Winnipeg, MB Canada R3T 6C6.
What is the SIC code for MEDICURE INC.?
The Standard Industrial Classification (SIC) code for MEDICURE INC. is 2834, which corresponds to Pharmaceutical Preparations.
Is MEDICURE INC. submitting this Form 6-K in paper format?
The filing indicates that MEDICURE INC. is not submitting the Form 6-K in paper format as permitted by Regulation S-T Rule 101(b)(1) or Rule 101(b)(7).
Filing Stats: 243 words · 1 min read · ~1 pages · Grade level 10.3 · Accepted 2024-10-24 18:15:35
Filing Documents
- med_6k.htm (6-K) — 10KB
- med_ex991.htm (EX-99.1) — 23KB
- med_ex991img1.jpg (GRAPHIC) — 3KB
- med_ex991img2.jpg (GRAPHIC) — 12KB
- 0001654954-24-013302.txt ( ) — 55KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Medicure Inc. (Registrant) Date: October 24, 2024 By: /s/ Dr. Albert D. Friesen Dr. Albert D. Friesen Title: CEO 3